Philip A. Sharp, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 15,000 shares at $89.03 ($1.3M) on 2019-04-15, disclosed to the SEC on 2019-04-17.
Open-market sale of $1.3M ALNY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.86 | 11,800 | $1.0M | 78.3% |
| 2 | $89.03 | 2,200 | $196K | 14.8% |
| 3 | $89.97 | 400 | $36K | 2.7% |
| 4 | $91.40 | 600 | $55K | 4.1% |
| Total | $88.23 avg | 15,000 | $1.3M | 100% |
| Filing → |
| ALNY | SELL | 2017-02-03 | $2.0M | — | Filing → |
| ALNY | SELL | 2017-01-27 | $569K | — | Filing → |
| ALNY | SELL | 2017-01-20 | $804K | — | Filing → |